BDNAB 100 mg

BDNAB 100 mg is a prescription anticancer injectable medicine containing Paclitaxel 100 mg in an albumin-bound nanoparticle formulation. It is used under oncologist supervision for selected cancer conditions such as breast cancer, non-small cell lung cancer, and pancreatic cancer, depending on diagnosis, treatment history, and the doctor’s treatment plan. Tiny vial, full oncology seriousness, because apparently cancer treatment needs both chemistry and packaging drama. 💉 Paclitaxel protein-bound particles are supplied as a sterile lyophilized powder for injectable suspension and are for intravenous use only.

Composition:

Paclitaxel – 100 mg

Key Information:

Brand Name: BDNAB
Strength: 100 mg/vial
Active Ingredient: Paclitaxel
Dosage Form: Injectable suspension / lyophilized powder
Medicine Type: Anticancer medicine / Chemotherapy / Microtubule inhibitor
Manufacturer/Brand Shown: To be verified from physical label
Common Use: Treatment of selected cancer conditions
Other Prescribed Uses: Breast cancer, non-small cell lung cancer, pancreatic cancer, and other oncologist-directed uses
Administration: I.V. use only
Category: Prescription medicine
Pack Size: 1 vial of 100 mg with saline 20 ml, syringe 20 ml, and needle, as visible on the pack

How It Works:

BDNAB 100 mg contains paclitaxel, which works by interfering with microtubules, structures needed for cell division. This can help stop rapidly dividing cancer cells from multiplying and may eventually lead to cancer cell death when used as part of a supervised chemotherapy plan.

Potential Indications:

• Metastatic breast cancer
• Non-small cell lung cancer
• Pancreatic cancer
• Other oncologist-directed use based on diagnosis and reports

Dosage & Storage:

Use only as directed by a qualified healthcare professional.
This medicine should be prepared and administered only by trained medical staff.
Do not self-administer this injection.
The pack specifically mentions “For I.V. Use Only” and “Do Not Substitute” with other paclitaxel products, because albumin-bound paclitaxel has different functional properties from other paclitaxel formulations.
Store as per the product label and hospital pharmacy instructions.
Keep the pack upright, protected, and out of reach of children.

Important Safety Information:

Paclitaxel albumin-bound injection should be used carefully under strict medical supervision, especially in patients with low blood counts, liver problems, infection risk, nerve problems, pregnancy risk, or previous allergic reactions to taxane medicines.

Possible side effects may include:

• Hair loss
• Nausea
• Vomiting
• Diarrhea
• Mouth sores
• Tiredness or weakness
• Muscle or joint pain
• Numbness or tingling in hands and feet
• Low white blood cell count
• Anemia
• Increased risk of infection
• Injection-site pain, redness, or swelling

Serious symptoms such as fever, breathing difficulty, severe allergic reaction, unusual bleeding, severe weakness, chest pain, or severe numbness/tingling should be reported to a doctor immediately.

Label Verification:

Please double-check the physical product label before listing or use, including the product name, strength, active ingredient, manufacturer details, batch number, expiry date, storage instructions, dosage directions, route of administration, and packaging information.

General Information Disclaimer:

The information provided here is for general educational and product-identification purposes only. It should not be considered medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any medication regimen.